Skip to content

Clinical study for relieving symptoms of moderate and severe overactive bladder by electroacupuncture

Efficacy evaluation for electroacupuncture in the treatment of neurogenic urinary retention and overactive bladder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019928
Enrollment
Unknown
Registered
2018-12-09
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

overactive bladder

Interventions

electroacupuncture group:Electroacupuncture therapy was performed 3 times/week for the first 4 weeks and 2 times/week for the last 8 weeks, a total of 28 times
weak electroacupuncture group:Weak electroacupuncture stimulation was performed 3 times/week for the first 4 weeks and 2 times/week for the last 8 weeks, a total of 28 times
Drug treatment group:Solifenacin succinate was given 5mg once a day for 32 weeks

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Participants who meet the following critiria will be included: 1) Patients with overactive bladder who meet the diagnostic criteria of International Continence Society (ICS) and American urological association (AUA); 2) aged 18-75 years; 3) the duration of the disease is more than 3 months; 4) the overactive bladder symptom score (OABSS) is greater than or equal to 6 points; 5) sign the informed consent and participate in the experiment voluntarily.

Exclusion criteria

Exclusion criteria: Participants with any of the following conditions will be excluded: 1) frequency and urgency of urination secondary to other diseases (secondary overactive bladder); 2) patients with mixed urinary incontinence; 3) patients with uncontrolled symptomatic urinary tract infection; 4) pelvic organ prolapse is greater than or equal to grade II; 5) residual urine volume of the bladder is greater than or equal to 100ml; 6) metal allergy or severe fear of acupuncture, electroacupuncture treatment can not tolerate; 7) allergic to solina or contraindicated use of anti-toadstool drugs; 8) uncontrolled diabetes, severe heart, liver, kidney, mental illness or coagulation dysfunction; 9) placement of pacemakers; 10) pregnant or lactating patients, or pregnant intentionally for nearly one year; 11) those who have used relevant therapeutic drugs or acupuncture therapy within 1 month; 12) participants in other subjects.

Design outcomes

Primary

MeasureTime frame
overactive bladder symptom score;

Secondary

MeasureTime frame
The average urination frequency was 24 hours, night urination frequency, urination incontinence frequency and urination urgency frequency;OAB-q;Average 24 hours of drinking water analysis;

Countries

China

Contacts

Public ContactLi Ning

West China Hospital ,Sichuan University

zhenjiuhuaxi@163.com+86 18980601617

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026